Evidence map›Paper›PMID 42294712›Full record

ArticleMicrobiology spectrum2026

Specific and broad-spectrum antibacterial effectors of type VI secretion system drive competition of

Boris Taillefer, Yassine Dairy, Agathe Brault, Martial Briand, Pierre Charpin, Jean Armengaud, Alain Sarniguet

Abstract read
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Boris TailleferUniv Angers, Institut Agro, INRAE, IRHS, SFR QUASAV, Angers, France.ORCID 0009-0003-3949-751X
Yassine DairyUniv Angers, Institut Agro, INRAE, IRHS, SFR QUASAV, Angers, France.
Agathe BraultUniv Angers, Institut Agro, INRAE, IRHS, SFR QUASAV, Angers, France.
Martial BriandUniv Angers, Institut Agro, INRAE, IRHS, SFR QUASAV, Angers, France.ORCID 0000-0002-5822-2824
Pierre CharpinDépartement Médicaments et Technologies pour la Santé, Université Paris-Saclay, CEA, INRAE, Bagnols-sur- Cèze, France.
Jean ArmengaudDépartement Médicaments et Technologies pour la Santé, Université Paris-Saclay, CEA, INRAE, Bagnols-sur- Cèze, France.ORCID 0000-0003-1589-445X
Alain SarniguetUniv Angers, Institut Agro, INRAE, IRHS, SFR QUASAV, Angers, France.ORCID 0000-0001-6232-0200

Funding

Angers Loire Métropole T6IMPACTInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement T6ImpactUniversity Angers T6IMPACT
6 · The paper itself

Abstract

The type VI secretion system (T6SS) is a bacterial weapon that injects deadly effectors (T6Es) directly into a target competitor encountered in a microbial community.

Indexed as

Anti-Bacterial AgentsMicrobiotaSeedsStenotrophomonasType VI Secretion SystemsAntibiosisBacteriaBacterial ProteinsAnti-Bacterial AgentsBacterial ProteinsType VI Secretion Systemseffectorinterbacterial competitionregulationsecretion systemseed microbiotaT6SStoxin-antitoxin

Identifiers

PMID42294712
PMCPMC13340143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.